HAS3 and lip and oral cavity carcinoma: Despite the detection of both HAS1 and HAS2 in oral cancer cells, their expression levels were lower than that of HAS3 in most oral cancer cell lines (Figure 1A) not to mention that HAS1 and HAS2 are catalytically less active than HAS3 in HA synthesis [41].